![Former American Cancer Society CEO John Seffrin endorses cancer research venture funded by Philip Morris](https://cdn.cancerletter.com/media/2017/10/smokebomb-websmall.jpg)
![Former American Cancer Society CEO John Seffrin endorses cancer research venture funded by Philip Morris](https://cdn.cancerletter.com/media/2017/10/smokebomb-websmall.jpg)
Cover Story
Free
Philip Morris International, the tobacco company, is spending $1 billion over 12 years on “cancer research,” which will be funded through something called the Foundation for a Smoke-Free World.
In Brief
Drugs & Targets
Trending Stories
- Lei Zheng named executive director of Mays Cancer Center
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”